The aim of this study was to try to generate a panel of monoclonal antibodies that could be used to probe the structure and function of the DNA-binding domain of herpes simplex virus type 1 (HSV-1) immediate early (IE) polypeptide Vmw175. Protein I9X, which contains residues 252 to 523 of Vmw175, was purified from bacteria as described (Everett et al., 1991) . The I9X protein was used to immunize mice, which were subsequently the donors for hybridoma fusions. A total of 22 hybridoma lines were obtained (of which three subsequently ceased to produce antibody), after screening for the production of monoclonal antibodies directed against the Vmw175 DNA-binding domain. The screening method was an ELISA, using wells that had been coated with purified protein I10X (Vmw175 residues 276 to 523; Everett et al., 1991) .
The approximate positions of the epitopes recognized by these clones were determined by ELISAs using wells coated with crude extracts from bacteria that expressed truncated versions of the I10X protein.
The construction of plasmid pT7I 10X and the methods of induction of its expression and purification have been described (Everett et al., 1991) . The plasmids expressing the truncated versions of the domain were constructed in the same way as plasmid pT7110X, using fragments derived from the EeoRI linker insertion mutants pI11, pI12, pI14 and pI16 (Paterson & Everett, 1988) . Plasmid pT7110H57 was derived from plasmid pT7110 by sitedirected mutagenesis; it contains a frameshift mutation at residue 452 (K. E. Allen & R. D. Everett, unpublished) . Plasmid pT7110XS was derived from plasmid pT7110X; it contains an XbaI linker which terminates translation at codon 491. This protein is the smallest version of an active Vmw175 DNA-binding domain yet obtained (R. D. Everett, unpublished) . Bacteria harbouring these plasmids were grown in 100ml cultures, induced with IPTG and the bacteria were harvested by centrifugation 2 h later. The cells were lysed with lysozyme and detergent as described (Everett et al., 1991) . The extracts were clarified by centrifugation, and the DNA-binding domain proteins concentrated by precipitation with ammonium sulphate at 30% saturation. The extracts were used without further purification to coat 96-well dishes for ELISAs (extract from the equivalent of 2 ml of induced culture was used for each well). The assays used undiluted hybridoma culture supernatant (50/zl), and then horseradish peroxidaseconjugated sheep anti-mouse Ig with the Scottish Antibody Production Unit horseradish peroxidase substrate.
On the basis of these results, the monoclonal antibodies could be grouped into four classes, as summarized in Fig. 1 . Class I monoclonal antibodies, which recognized epitopes with critical features between residues 276 and 292, were the most numerous. These antibodies exhibited some differences in their behaviour in other assays, such as Western blotting, immune precipitation or recognition of protein bound to DNA probes, so they either recognized the same epitope with different affinities or they recognized different epitopes within this small region (data not shown). Class II and III monoclonal antibodies, which recognized epitopes with boundaries between residues 310 and 329, and 329 and 373 respectively, were represented by one monoclonal antibody each. Class IV had two representatives, with epitopes between residues 454 and 523. The epitope of class IV antibody 10343 was further mapped to within residues 454 and 490 (Fig. 1) . A selection of the hybridoma cell lines was used to generate ascites fluids. The aim of this study was to try to isolate monoclonal antibodies that interfered with DNA binding, thus defining regions of the Vmw175 DNA-binding domain that were important for the ability to bind to DNA. Accordingly, gel retardation experiments using the IE-3 cap site probe and either the purified I10X protein or nuclear extracts from HSV-1 strain 17-infected BHK cells were carried out exactly as described (Everett et al., 1991) . The effect of adding a number of the monoclonal antibodies either before or after addition of the DNA The arrows point to HSV-1 Vmw175 and HSV-2 Vmw182. The VZV gene 62 product has a mobility indistinguishable from that of Vmw175. H denotes a host background band which is detected using the Amersham ECL system by most (but not all) of the monoclonal antibodies described in this study. (residues 417 to 646), VT4 (residues 462 to 646) and VT5 (residues 472 to 646) (lanes 2 to 4) were expressed in Escherichia coli (Tyler & Everett, 1993) and detected by Western blotting using monoclonal antibody 10084 at a dilution of 1 : 1000. Lane 1 contains a protein extract from a control E. eoli culture which did not harbour a VZV gene 62 expression plasmid. The sizes of the VT2X and VT4 polypeptides are dependent not only on the number of VZV gene 62 residues expressed, but also on the nature of these residues and the number of residues derived from the vector plasmid (Tyler & Everett, 1993) .
probe was studied. The results (not shown) indicated that most of the monoclonal antibodies had no effect on the DNA-protein complex, neither inhibiting its formation nor producing a further retarded species. Thus these monoclonal antibodies recognize epitopes that are either displayed solely in denatured protein, or hidden within properly folded protein. Four of the monoclonal antibodies gave low amounts of a supershifted species, and only two (10462 and 10343) were able to supershift the I10X protein-DNA complex in an almost quantitative manner. Thus the original aim of this project was not accomplished. During the course of screening antibodies for epitope recognition, their ability to detect the DNA-binding domain of the varicella-zoster virus (VZV) gene 62 protein was determined. These proteins are highly conserved, especially in region 2 (which comprises the majority of the DNA-binding domain) (McGeoch et al., 1986) . In the initial experiments, the target for the monoclonal antibodies was protein VT2, which was expressed in bacteria and includes the DNA-binding domain of VZV gene 62 (Tyler & Everett, 1993) . A number of the monoclonal antibodies gave a weak reaction against protein VT2 on Western blots, but 10084 was particularly strong, both on blots and in ELISAs (data not shown). It is unlikely that the epitope recognized by 10084 is present only in denatured protein since it gave weak positive results in both gel retardation supershift experiments and immune precipitations (data not shown).
To test whether this cross-reactivity extended to the complete VZV gene 62 product (and the corresponding products of other related alphaherpesviruses), monoclonal antibody 10084 was used to probe blots that contained extracts from BHK cells that had been infected with HSV-1, HSV-2, HSV140, pseudorabies virus (PRV) and equine herpesvirus type 1 (EHV-1). Virus HSV140 contains the VZV gene 62 in place of the HSV-1 IE-3 (Vmw175) gene in an HSV-1 background, and therefore serves as a convenient source of the VZV gene 62 protein (Disney & Everett, 1990) .
The results (Fig. 2) show that 10084 recognizes the HSV-2 Vmw 180 protein and the VZV gene 62 protein as strongly as it recognizes Vmw175. The PRV and EHV-1 proteins were not recognized by monoclonal antibody 10084. This result illustrates that the relationship between some of the members of this family of proteins extends beyond primary sequence conservation to presentation of very similar epitopes in the region of Vmw 175 residues 310 to 329. Interestingly, this is not one of the most highly conserved stretches of primary sequence within this DNA-binding domain family (Fig. 3) , which suggests that despite the differences in primary sequence in this region, the HSV-1 and VZV proteins can fold into similar structures. Western blots using truncated forms of the VZV gene 62 DNA-binding domain confirmed that the N terminus of the monoclonal antibody 10084 epitope is between gene 62 codons 462 and 472 (Fig. 3 b) .
Previous examples of proteins encoded by different members of the herpesvirus family with immunological cross-reactivity include the highly conserved glycoprotein B (Snowden et al., 1985) and the major DNA-binding protein (Littler et al., 1981) .
